Online Anticancer Drugs - MillionPharma

Drug profile   erlonat    is a Natco pharma item which is containing a functioning substance known as Erlotinib, a first line medication of decision in metastatic phase of non little cell lung tumor. erlonat  150mg  is normally endorsed for the patients who are not counters to less than one chemotherapy regimen. erlonat  150mg tablet  is synthetically described as quinazoline subordinate, with hostile to neoplastic impact against tumor cells. erlonat   is pharmacologically arranged as tyrosine kinase inhibitor. erlonat  150mg    is altogether raising the serum aminotransferase levels amid the treatment and this may causes liver wounds. erlonat  150mg tablet    tablets are containing 150mg of Erlotinib as a hostile to tumor specialist. PRODUCT DETAILS Brand name:  Erlonat    Active constituent: Erlotinib Strength: 150MG Mfg: Natco pharma Pack: 30 tablets per container Category: Anti-neoplastic agent Price : erlonat 150mg price in India Erlonat 150mg 

Herduo DESCRIPTION herduo 250mg tablet belongs to class of antineoplastic drugs which prevents the development and spreading of cancer cells all over the body. herduo 250mg is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs INDICATION herduo 250mg tablet  with combination of capecitabine is indicated for the treatment of advanced breast cancer after the failure of other cancer medicine. herduo 250mg  is also combined with letrozole is indicated for the treatment postmenopausal women with hormone receptor positive metastatic breast cancer. herduo 250mg tablet  is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase. herduo  prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with  herduo 250mg  created an additive effect in the 4 tumor cell lines tested. Development inhibits the  herduo 250mg tablet  tablet effect were examined in trastuz